AMPH
Amphastar Pharmaceuticals, Inc.
20.09
1 x 14.57
2 x 26.04
bid
ask
-
0.02
0.07%
10:03 AM
timesize
| Ytd | -25.00% | |
| 1y | -14.82% |
19.93
day range
20.35
16.65
52 week range
31.26
| Open | 20.35 | Prev Close | 20.10 | Low | 19.93 | High | 20.35 | Mkt Cap | 885.61M |
| Vol | 26.95K | Avg Vol | 622.93K | EPS | 1.66 | P/E | 12.10 | Forward P/E | 5.49 |
| Beta | 0.88 | Short Ratio | 11.61 | Inst. Own | 75.56% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 19.91 | 200-d Avg | 23.68 | 1yr Est | 31.29 |
| Income Statement | |||
| Total Revenue | 171.17M | ||
| Revenues (USD) | 171.17M | ||
| Cost of Revenue | 100.85M | ||
| Gross Profit | 70.32M | ||
| Operating Expenses | 56.69M | ||
| Research and Development Expense | 26.74M | ||
| Selling, General and Administrative Expense | 29.96M | ||
| Operating Income | 13.63M | ||
| Interest Expense | 6.55M | ||
| Income Tax Expense | 3.63M | ||
| Net Income | 6.42M | ||
| Net Income Common Stock | 6.42M | ||
| Net Income Common Stock (USD) | 6.42M | ||
| Consolidated Income | 6.42M | ||
| Earnings per Basic Share | 0.14 | ||
| Earnings per Basic Share (USD) | 0.14 | ||
| Earnings per Diluted Share | 0.14 | ||
| Earning Before Interest & Taxes (EBIT) | 16.61M | ||
| Earning Before Interest & Taxes (USD) | 16.61M | ||
| Weighted Average Shares | 45.32M | ||
| Weighted Average Shares Diluted | 46.46M | ||
| Balance Sheet | |||
| Cash and Equivalents | 171.17M | ||
| Cash and Equivalents (USD) | 171.17M | ||
| Investments | 123.21M | ||
| Investments Current | 123.21M | ||
| Trade and Non-Trade Receivables | 147.85M | ||
| Current Assets | 633.68M | ||
| Property, Plant & Equipment Net | 378.91M | ||
| Total Assets | 1.65B | ||
| Debt Current | 11.38M | ||
| Total Debt | 686.38M | ||
| Current Liabilities | 164.48M | ||
| Debt Non-Current | 675.00M | ||
| Total Liabilities | 874.77M | ||
| Accumulated Retained Earnings (Deficit) | 673.30M | ||
| Accumulated Other Comprehensive Income | -5.74M | ||
| Shareholders Equity | 773.39M | ||
| Shareholders Equity (USD) | 773.39M | ||
| Assets Non-Current | 1.01B | ||
| Total Debt (USD) | 686.38M | ||
| Goodwill and Intangible Assets | 559.62M | ||
| Inventory | 170.19M | ||
| Liabilities Non-Current | 710.29M | ||
| Trade and Non-Trade Payables | 152.69M | ||
| Tax Assets | 52.07M | ||
| Tax Liabilities | 6.34M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 16.49M | ||
| Net Cash Flow from Financing | -30.21M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 762.00K | ||
| Capital Expenditure | -9.51M | ||
| Issuance (Purchase) of Equity Shares | -29.49M | ||
| Issuance (Repayment) of Debt Securities | -29.00K | ||
| Net Cash Flow from Investing | -16.73M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -7.29M | ||
| Net Cash Flow from Operations | 47.84M | ||
| Effect of Exchange Rate Changes on Cash | -138.00K | ||
| Share Based Compensation | 9.27M | ||